This website will be unavailable from Friday, April 26, 2024 at 6:00 p.m. through Monday, April 29, 2024 at 7:00 a.m. due to data center maintenance.

	
Amend CSHB 2292 as follows:                                                  
	On page 168, between lines 15 and 16, insert a new SECTION 
2.105 to read as follows:
	SECTION 2.105.  STUDY:  REVENUE ENHANCEMENT RELATED TO 
MEDICAID VENDOR DRUG REBATE.
	(a)  A task force is created to study the prescription drug 
rebate system established and operated under the medical assistance 
program and other related programs.
	(b)  The commission shall establish a task force, composed of 
appropriate legislators, state agency personnel, and other 
appropriate personnel to study the prescription drug rebate system 
established and operated under the medical assistance program and 
other related programs.
	(c)  The study must include:                                            
		(1)  a background on the development and operation of 
the federal vendor drug rebate and state supplemental rebate 
system;
		(2)  a description of current and historical state 
efforts to develop and implement alternatives to the federal vendor 
drug rebate system;
		(3)  a review of any relevant case law or legal 
precedents related to the vendor drug rebate system;
		(4)  an analysis of state implementation, including 
attempted implementation, of an exemption of federal requirements, 
including the federal Social Security Act, related to vendor drug 
rebates, prior authorization provisions, and formulary; and,
		(5)  feasibility of developing either an alternative 
rebate system or other mechanism to enhance the state's share of 
prescription drug rebate.
	(d)  The study must be completed by December 1, 2004 and 
presented to the Governor and the presiding officers of each house, 
the House Committee on Appropriations, and the Senate Finance 
Committee.
	Renumber subsequent sections appropriately.